Gilead Sciences is a biopharmaceutical company headquartered in Foster City, California, known for its innovative antiviral therapies.
The company’s key products include HIV treatments like Biktarvy and Descovy, hepatitis C drugs such as Harvoni and Epclusa, and the COVID-19 treatment Veklury (remdesivir).
Gilead's revenue is primarily driven by pharmaceutical sales, with HIV treatments being the most significant contributors.
The company targets healthcare providers, patients, and public health organizations globally, particularly in the U.S. and Europe.
Major competitors include GlaxoSmithKline, AbbVie, and Merck, making the biopharmaceutical industry highly competitive and research-driven.
Негізгі бет Gilead Sciences Business Summary
Пікірлер